- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 135.93M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $921.36K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $959.37K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $921.36K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $959.37K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $35.66K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $189.89K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $575.13K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $738.37K |
| Net Income | Q1 2025 · Dec 31, 2024 | −$133.22K |
| Net Income | Q1 2025 · Sep 30, 2024 | −$95.89K |
| Net Income | Q1 2025 · Jun 30, 2024 | −$110.95K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$170.65K |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | −$88.23K |
| Stockholders Equity | Q1 2025 · Jun 30, 2024 | $7.52K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $107.47K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $255.31K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 123.81M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$177.73K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $102.7K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $290.41K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $136.57K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$167.49K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |